A Securities and Exchange Commission investigation found that consultant Hoau-Yan Wang, PhD, an associate professor at the City University of New York, manipulated the clinical trial data using unblinded information, creating a false impression of significant improvements in biomarkers related to Alzheimer’s.
In addition to financial penalties, Mr. Barber and Dr. Burns agreed to bars of three and five years, respectively, from serving as officers or directors. The settlements are pending court approval, and Dr. Wang faces a $50,000 penalty for his role.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.